- Serum Thioredoxin 1 Level Has Close Relation with Myocardial Damage Amount in Acute Myocardial Infarction Patients
-
Shim YK, Kim JT, Seong MH, Kim YJ, Shim TJ, Kim SM, Lee SY, Bae JW, Kim KS, Hwang KK, Kim DW, Cho MC
- KMID: 1778821
- J Korean Med Sci.
- 2012 Oct;27(10):1162-1169.
- doi: 10.3346/jkms.2012.27.10.1162
Thioredoxin-1 (Trx-1) is one of important anti-oxidative molecules to overcome the oxidative stress. The aim of the present study is to investigate the clinical relationship between serum concentration of Trx-1... -
- CITED
-
- Close
- SHARE
-
- Close
- Heart-type Fatty Acid Binding Protein as an Adjunct to Cardiac Troponin-I for the Diagnosis of Myocardial Infarction
-
Kim KS, Lee HJ, Kim K, Jo YH, Kim TY, Lee JH, Rhee JE, Suh GJ, Kim MR, Lee CC, Singer AJ
- KMID: 1777975
- J Korean Med Sci.
- 2011 Jan;26(1):47-52.
- doi: 10.3346/jkms.2011.26.1.47
We hypothesized that when used in combination with cardiac troponins, heart-type fatty acid binding protein (H-FABP) would have greater diagnostic value than conventional markers for the early diagnosis of myocardial... -
- CITED
-
- Close
- SHARE
-
- Close
- A Randomized Study Assessing the Effects of Pretreatment with Cilostazol on Periprocedural Myonecrosis after Percutaneous Coronary Intervention
-
Kim BK, Oh SJ, Yoon SJ, Jeon DW, Ko YG, Yang JY
- KMID: 1108062
- Yonsei Med J.
- 2011 Sep;52(5):717-726.
- doi: 10.3349/ymj.2011.52.5.717
PURPOSE: It is unknown whether cilostazol pretreatment reduces postprocedural myonecrosis (PPMN). Cilostazol pretreatment reduces PPMN after percutaneous coronary intervention (PCI). MATERIALS AND METHODS: A total of 120 patients with stable angina... -
- CITED
-
- Close
- SHARE
-
- Close
